197 related articles for article (PubMed ID: 10655384)
1. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
Dorn J; Masciotra S; Yang C; Downing R; Biryahwaho B; Mastro TD; Nkengasong J; Pieniazek D; Rayfield MA; Hu DJ; Lal RB
J Clin Microbiol; 2000 Feb; 38(2):773-80. PubMed ID: 10655384
[TBL] [Abstract][Full Text] [Related]
2. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
3. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection.
Eberle J; Loussert-Ajaka I; Brust S; Zekeng L; Hauser PH; Kaptue L; Knapp S; Damond F; Saragosti S; Simon F; Gürtler LG
J Virol Methods; 1997 Aug; 67(1):85-91. PubMed ID: 9274821
[TBL] [Abstract][Full Text] [Related]
4. Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.
Zouhair S; Roussin-Bretagne S; Moreau A; Brunet S; Laperche S; Maniez M; Barin F; Harzic M
J Clin Microbiol; 2006 Feb; 44(2):662-5. PubMed ID: 16455942
[TBL] [Abstract][Full Text] [Related]
5. Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.
Oldstone MB; Tishon A; Lewicki H; Dyson HJ; Feher VA; Assa-Munt N; Wright PE
J Virol; 1991 Apr; 65(4):1727-34. PubMed ID: 2002540
[TBL] [Abstract][Full Text] [Related]
6. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples.
van Binsbergen J; Keur W; vd Graaf M; Siebelink A; Jacobs A; de Rijk D; Toonen J; Zekeng L; Afane Ze E; Gürtler LG
J Virol Methods; 1997 Dec; 69(1-2):29-37. PubMed ID: 9504748
[TBL] [Abstract][Full Text] [Related]
8. Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.
Calarota S; Jansson M; Levi M; Broliden K; Libonatti O; Wigzell H; Wahren B
AIDS Res Hum Retroviruses; 1996 May; 12(8):705-13. PubMed ID: 8744581
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
Mitchell WM; Ding L; Gabriel J
AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies against an immunodominant region of the HIV-1 envelope glycoprotein gp41 in sera from HIV-1 infected individuals in Brazil.
Bongertz V; Morgado MG
Mem Inst Oswaldo Cruz; 1994; 89(3):369-70. PubMed ID: 7476219
[TBL] [Abstract][Full Text] [Related]
12. Recombinant proteins derived from immunodominant regions of the gag and env genes of HIV-1 and their potential for use in serologic diagnosis.
Kovác J
Acta Virol; 1991 Aug; 35(4):383-90. PubMed ID: 1686963
[TBL] [Abstract][Full Text] [Related]
13. Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals.
Enshell-Seijffers D; Smelyanski L; Vardinon N; Yust I; Gershoni JM
FASEB J; 2001 Oct; 15(12):2112-20. PubMed ID: 11641237
[TBL] [Abstract][Full Text] [Related]
14. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
Clin Exp Immunol; 1992 Jan; 87(1):37-45. PubMed ID: 1370773
[TBL] [Abstract][Full Text] [Related]
15. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda.
Brennan CA; Lund JK; Golden A; Yamaguchi J; Vallari AS; Phillips JF; Kataaha PK; Jackson JB; Devare SG
AIDS; 1997 Dec; 11(15):1823-32. PubMed ID: 9412700
[TBL] [Abstract][Full Text] [Related]
16. Genetic variability of principal neutralizing determinants on HIV-1 gp41 and its correlation with subtypes.
Dong XN; Ying J; Wu Y; Chen YH
Immunol Lett; 2005 Oct; 101(1):104-7. PubMed ID: 15961163
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
[TBL] [Abstract][Full Text] [Related]
18. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus.
Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470
[TBL] [Abstract][Full Text] [Related]
19. Recombinant multi-epitope vaccine induce predefined epitope-specific antibodies against HIV-1.
Li H; Liu ZQ; Ding J; Chen YH
Immunol Lett; 2002 Nov; 84(2):153-7. PubMed ID: 12270553
[TBL] [Abstract][Full Text] [Related]
20. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].
Isaguliants MG; Koshida R; Ruden U; Varen B
Biokhimiia; 1996 Jul; 61(7):1221-9. PubMed ID: 9035735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
